US equities
|
NVDA
$234.46
▲+1.56%
MU
$1,074.57
▼-2.08%
SPCX
$158.66
▲+7.15%
TSLA
$371.41
▲+4.89%
SNDK
$1,723.89
▼-3.57%
STX
$848.52
▼-10.26%
AMD
$631.32
▲+2.53%
WDC
$422.10
▼-8.75%
NVDA
$234.46
▲+1.56%
MU
$1,074.57
▼-2.08%
SPCX
$158.66
▲+7.15%
TSLA
$371.41
▲+4.89%
SNDK
$1,723.89
▼-3.57%
STX
$848.52
▼-10.26%
AMD
$631.32
▲+2.53%
WDC
$422.10
▼-8.75%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Sirnaomics Ltd.
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases
July 23, 2024
From
Sirnaomics Ltd.
Via
ACN Newswire
Sirnaomics Ltd., the RNA Therapeutics Biopharmaceutical Company with Strong Presence in Both China and the U.S. Successfully Listed on Main Board of SEHK
December 30, 2021
From
Sirnaomics Ltd.
Via
ACN Newswire
Sirnaomics Ltd. Announces Proposed Listing on the Main Board of SEHK
December 19, 2021
From
Sirnaomics Ltd.
Via
ACN Newswire